Cancer Studies
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit ManuscriptAbout the Journal
Cancer Studies is an international, peer-reviewed, open-access journal publishing high-quality research, reviews, case studies, short communications, and scholarly perspectives.
The journal welcomes contributions in Cancer biology, oncology, diagnostics, prevention, therapeutics, clinical studies, and survivorship research. It supports authors, editors, and reviewers through transparent editorial handling, ethical peer review, and timely publication workflows.
Scope of the Journal
- Original research and evidence-based reviews
- Clinical, laboratory, engineering, or field studies relevant to the discipline
- Method development, technology applications, and interdisciplinary work
- Case reports, short communications, perspectives, and editorial commentary
- Open-access dissemination for researchers, practitioners, and institutions
Open Access Statement
All accepted articles are published for broad visibility and responsible reuse with attribution. Authors retain appropriate scholarly credit while readers receive immediate access to published work.
Recent Articles
The Roles of Microenvironment in Tumor Dormancy
Matthew R Eber, Kenji Yumoto, Janice E Berry, Russell S Taichman and Yusuke Shiozawa • 26 Aug 2026
Several studies have shown that metastatic cancer cells may lie dormant in a secondary site for more than a decade, all the while retaining the ability to aggressively reemerge. Once these dormant cancer cells regrow, cancer becomes incurable, yet the mechanisms that instruct metastatic cancer cells to become dormant and later escape from dormancy still remain unknown. In this review we will discuss the known regulatory roles of the microenvironment in tumour dormancy and some potential models for future studies of tumour dormancy. Better understanding of the mechanisms involved has the potential to lead to significant improvements in the care of advanced cancer patients and the prevention of cancer recurrence.
Emerging Paradigms for Small Molecules-Based Therapies Targeting P53 in multiple myeloma
Manujendra N Saha • 01 Feb 2015
Experimental Study of Doxorubicin Interventional Chemotherapy in the Treatment of Rabbit VX2 Renal Transplantation Carcinoma
Zhao Shuyuan*1, Yu Hui1 and Du Nan2 • 15 Jan 2015
Objective to study the effect of doxorubicin interventional chemotherapy on rabbit VX2 renal transplantation carcinoma and its mechanism. Methods Thirty healthy New Zealand white rabbits were chosen to establish VX2 renal transplantation carcinoma models. The experimental rabbits were randomly divided into three groups with 10 rabbits in each group. The rabbits in the control group (negative control), doxorubicin group and cisplatin group were treated with saline, 5mg/kg doxorubicin and 2mg/kg cisplatin respectively. The tumour volume was monitored with B-mode ultrasonography. The rabbits were anesthetized and killed after two weeks of interventional chemotherapy. The changes of Bcl-2 and Bax at the levels of mRNA and protein were analysed with real-time PCR and immunohistochemistry. Results The efficacy of interventional chemotherapy was evaluated with tumour volume changes monitored by B-mode ultrasonography. The tumour volume of control group and doxorubicin group was 1.29±0.60cm3 and 0.47±0.12 cm3 respectively. Further fluorescence quantitative PCR detection results showed that doxorubicin could reduce the Bcl-2 expression and increase the Bax expression (P<0.05). The result of immunohistochemistry was consistent with that of fluorescence quantitative PCR.
Conclusions: The effect of doxorubicin interventional chemotherapy on renal transplantation carcinoma is obvious and the mechanism may be related to the downregulation of Bcl-2 expression and up-regulation of Bax expression thus inducing the apoptosis of tumour cells
The Preoperative Sequential Administration of GM-CSF and IL-2 at the Primary Site of Cutaneous Melanoma Can Induce Immense Specific Antitumor Response: A potential New Approach to Adjuvant Immunotherapy
E George Elias1* and Bhuvnesh K Sharma2 • 12 Dec 2014
The Future of Telerehabilitation in Lung Cancer: An Observational Study Investigating Access to Technology in the Lung Cancer Population
Catherine L Granger1, 2, 3*, Lara Edbrooke1 and Linda Denehy1, 3 • 22 Nov 2014
A growing body of evidence supports the efficacy of exercise training in the management of lung cancer. Home-based telerehabilitation may be a favourable model; however limited information is available about technology access, use and competency specifically in the
lung cancer population.
Aims: To identify the proportion of patients with lung cancer who access and use mobile phones, tablet devices or computers; and the patient profile of such individuals.
Method: 23 participants (17 male, median ages 71 [IQR 63-72] years) with stage I-III non-small cell lung cancer, 1-13 months post diagnosis completed a technology questionnaire. Additional measures completed at time of diagnosis include: comorbidities, Eastern Cooperative Oncology Group- Performance Status (function), six minute walk distance (functional exercise capacity) and questionnaires (physical activity levels, symptoms, mood,
health-related quality of life).
Results: 70% (n=16/23) of participants had a mobile phone, 4% (n=1/23) had a tablet device and 43% (n=10/23) had a computer. Thirty percent (n=7/23) of participants did not have a mobile phone, tablet device or computer; these individuals were older (p=0.013), had greater comorbidities (p=0.028), lower functional exercise capacity (p=0.048); and worse fatigue (p=0.002) and pain (p=0.006). The majority of participants with mobile phones did not have a smart phone (69%) and no participants used the internet on their phone. Seventeen percent (n=4/23) of participants used the internet daily on a computer, all other participants used the internet once a month or less. Only 13% (n=3/23) of participants rated their computer skills as adequate or higher. Skype and Facebook were only used by one participant.
Conclusion: Access and use of smart phones, tablet devices and computers is relatively infrequent in an elderly population with early stage lung cancer from a tertiary acute hospital setting. Further studies are warranted to explore the acceptability of technology in the delivery of exercise rehabilitation in this population.